WFRF:(Svensson Torgny)
Sökning: WFRF:(Svensson Torgny) > (2015-2019) > Alpha7 nicotinic ac...
Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study.
-
- Marcus, Monica M (författare)
- Karolinska Institutet
-
- Björkholm, Carl (författare)
- Karolinska Institutet
- Malmerfelt, Anna (författare)
- visa fler...
- Möller, Annie (författare)
- Påhlsson, Ninni (författare)
- Schilström, Björn (författare)
- visa färre...
- (creator_code:org_t)
- Elsevier BV, 2016
- 2016
- Engelska.
- Ingår i: European Neuropsychopharmacology. - : Elsevier BV. - 0924-977X .- 1873-7862. ; 26:9, s. 1401-11
- Tidskriftsartikel (refereegranskat)
Abstract
Ämnesord
Stäng
- Nicotine has been found to improve cognition and reduce negative symptoms in schizophrenia and a genetic and pathophysiological link between the α7 nicotinic acetylcholine receptors (nAChRs) and schizophrenia has been demonstrated. Therefore, there has been a large interest in developing drugs affecting the α7 nAChRs for schizophrenia. In the present study we investigated, in rats, the effects of a selective α7 agonist (PNU282987) and a α7 positive allosteric modulator (PAM; NS1738) alone and in combination with the atypical antipsychotic drug risperidone for their utility as adjunct treatment in schizophrenia. Moreover we also investigated their utility as adjunct treatment in depression in combination with the SSRI citalopram. We found that NS1738 and to some extent also PNU282987, potentiated a subeffective dose of risperidone in the conditioned avoidance response test. Both drugs also potentiated the effect of a sub-effective concentration of risperidone on NMDA-induced currents in pyramidal cells of the medial prefrontal cortex. Moreover, NS1738 and PNU282987 enhanced recognition memory in the novel object recognition test, when given separately. Both drugs also potentiated accumbal but not prefrontal risperidone-induced dopamine release. Finally, PNU282987 reduced immobility in the forced swim test, indicating an antidepressant-like effect. Taken together, our data support the utility of drugs targeting the α7 nAChRs, perhaps especially α7 PAMs, to potentiate the effect of atypical antipsychotic drugs. Moreover, our data suggest that α7 agonists and PAMs can be used to ameliorate cognitive symptoms in schizophrenia and depression.
Nyckelord
- Antidepressants
- Antipsychotics
- Cognition
- Dopamine
- Electrophysiology
- Nicotine
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
- European Neuropsychopharmacology (Sök värdpublikationen i LIBRIS)
Till lärosätets databas
Hitta mer i SwePub
- Av författaren/redakt...
- Marcus, Monica M
- Björkholm, Carl
- Malmerfelt, Anna
- Möller, Annie
- Påhlsson, Ninni
- Konradsson-Geuke ...
- visa fler...
- Feltmann, Kristi ...
- Jardemark, Kent
- Schilström, Björ ...
- Svensson, Torgny ...
- visa färre...
- Artiklar i publikationen
- European Neurops ...
- Av lärosätet
- Uppsala universitet
- Karolinska Institutet
Sök utanför SwePub
- Sök vidare i:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - Nationella bibliotekssystem
- LIBRIS.kb.se
